Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

9.4K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.4K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.0K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.0K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

1.1K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.1K
Nonlinear Pharmacokinetics: Causes of Nonlinearity01:22

Nonlinear Pharmacokinetics: Causes of Nonlinearity

718
Nonlinearity in drug pharmacokinetics is caused by various factors influencing how a drug is absorbed, distributed, metabolized, and excreted. Understanding these nonlinear processes is crucial for predicting drug behavior in the body and optimizing drug dosing regimens.
Nonlinear drug absorption can occur when the process is rate-limited by solubility, carrier-mediated transport systems, or saturation of the presystemic gut wall or hepatic metabolism. For instance, high doses of riboflavin...
718
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.1K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.1K
Cholinergic Antagonists: Pharmacokinetics01:24

Cholinergic Antagonists: Pharmacokinetics

938
Cholinergic antagonists—such as antimuscarinics—are available in oral, topical, ocular, parenteral, and inhalational formulations. Most antimuscarinics are oral formulations,  while scopolamine is available as a topical patch, and ipratropium and tiotropium are available as inhalation aerosols or powders. Atropine, tropicamide, and cyclopentolate are topically instilled in the eye. Most antimuscarinics are lipid-soluble and readily absorbed from the gastrointestinal tract and...
938

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

A methotrexate dashboard: integrating MTXPK.org into the electronic health record to facilitate model-informed care for pediatric patients receiving high-dose methotrexate.

JAMIA open·2026
Same author

Clinical Model-Informed Precision Dosing Consult Service for Accelerating Personalized Medication in Pediatric Patients.

Clinical pharmacology and therapeutics·2026
Same author

Use of a Cystatin C-Based GFR Equation in a Population Pharmacokinetic Model of Methotrexate Clearance in Adult Patients with Lymphoma.

Clinical pharmacokinetics·2026
Same author

Pharmacogenetic hSLCO1B1*14-Guided Dosing of Methotrexate in Transgenic Arthritic Mice Normalizes Exposure and Response.

Clinical and translational science·2025
Same author

Building a Beta-Lactam Model-Informed Precision Dosing Service in a Quaternary Care Children's Hospital.

Clinical and translational science·2025
Same author

Beyond Alzheimer's disease-translating biomarker insights across CNS diseases.

Science translational medicine·2025

相关实验视频

Updated: Jan 28, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.7K

药理动力学作为生物标志物

John A Wagner1, Sonal Singh2, Zachary L Taylor3,4,5

  • 1Aditum Bio, Tempero Bio, and Trames Bio, Cambridge, Massachusetts, USA.

Clinical and translational science
|January 27, 2026
PubMed
概括

药理动力学 (PK) 是一种生物标志物,将药物剂量与患者反应联系起来. 了解PK作为生物标志物可以促进药物开发和精准医学应用.

关键词:
生物标志物 生物标志物药理动力学是药理动力学的一个方面.药物动力学 药物动力学

更多相关视频

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

相关实验视频

Last Updated: Jan 28, 2026

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD
08:29

Biomarkers in an Animal Model for Revealing Neural, Hematologic, and Behavioral Correlates of PTSD

Published on: October 10, 2012

16.7K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

33.3K
An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

8.6K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 生物标志物发现发现
  • 翻译医学是一种翻译医学.

背景情况:

  • 药理动力学 (PK) 传统上是与药理动力学 (PD) 和生物标志物分开的.
  • 这种分离忽略了PK的显著转换值.
  • 在过渡剂量,暴露和反应中PK的作用往往被低估.

研究的目的:

  • 将药理动力学 (PK) 作为生物标志物重新定义.
  • 突出PK在连接药物剂量,暴露和生理反应中的功能.
  • 证明PK在各种临床环境中作为生物标志物的实用性.

主要方法:

  • 概念视角整合现有知识.
  • 来自各种药理学领域的说明性示例.
  • 与临床结果相关的PK数据的分析.

主要成果:

  • PK作为一个可测量,预测和可操作的生物标志物.
  • 这些例子证明了PK在向中介药物排放,抗药抗体和脑脊液药物水平中的作用.
  • 在高剂量甲状腺素治疗和抗感染治疗中,PK指导决策.

结论:

  • 应识别药理动力学 (PK) 并将其用作生物标志物.
  • 将PK视为生物标志物可以推进精准医学,并优化药物开发策略.
  • 这种观点增强了PK研究的翻译相关性.